About
Since the completion of the Human Genome Project nearly a decade ago, continuing technological and scientific progress has brought significant advances to the fields of genomics and personalized medicine. As researchers, entrepreneurs, investors and businesses have sought to harness these advances, they have received increasing scrutiny from politicians, regulators, judges and policymakers. This, in turn, has brought a new layer of complexity to an already complicated legal and regulatory landscape.
The Genomics Law Report, a publication of the law firm Robinson, Bradshaw & Hinson, analyzes the legal implications of important developments in the fields of genomics and personalized medicine — including key litigation, legislative, regulatory and policymaking activities — to help make sense of these complex and rapidly changing areas of law and policy.
GLR Editor
 |
John Conley is Kenan Professor of Law at the University of North Carolina and of counsel to Robinson, Bradshaw & Hinson, where he specializes in intellectual property and biotechnology. Full Bio |
GLR Contributing Editor
 |
Jennifer K. Wagner conducts multidisciplinary research at the University of Pennsylvania’s Center for the Integration of Genetic Healthcare Technologies (Penn CIGHT). She is also a licensed attorney practicing in Pennsylvania. Jennifer earned her Juris Doctorate from the University of North Carolina School of Law in 2007 and her Doctorate of Philosophy in Anthropology from the Pennsylvania State University in 2010.Jennifer has published works in law reviews (i.e. Virginia Sports & Entertainment Law Journal and North Carolina Journal of Law and Technology) and scientific journals (e.g. American Journal of Human Genetics, Genetics in Medicine, Nature Medicine, and Perspectives in Biology and Medicine). She is a member of the Ethics Committee for the American Association of Physical Anthropologists and is an academic editor for PeerJ.
Follow Jennifer on Twitter @DNAlawyer |
